MORNING BID 🔸 $CWAN acquires $ENFN for $11.25/share, totaling $1.5B, including $30M to end Enfusion's tax agreement. 🔸 $NVDA and $AMD drop due to new U.S. AI chip export controls, effective in 120 days. 🔸 $UNH, $CI, $CVS, $HUM up after U.S. proposes 2.2% increase in 2026 Medicare Advantage payments. 🔸 $SAGE confirms $BIIB $7.22/share acquisition proposal. 🔸 $EXAS reports Q4 revenue $713M, FY24 $2.76B; plans three new cancer tests in 2025. 🔸 $HOLX Q1 revenue $1.022B, slightly below expectations due to currency impact. 🔸 $JNJ to buy $ITCI for $132/share, valuing deal at $14.6B. 🔸 $NTRA Q4 revenue $472M, FY24 guidance $1.7B. 🔸 $RXST FY25 revenue guidance $185M-$197M, gross margin 71%-73%. 🔸 $BEN AUM dropped to $1.58T in Dec '24 from $1.65T in Nov '24 due to market downturn and $18.9B net outflows. 🔸 $LZ upgraded by JPMorgan to Overweight from Underweight, price target raised to $9 from $8. 🔸 $CLMT secured a $1.44B DOE loan to expand its Montana Renewables facility. 🔸 Biden admin delayed Nippon Steel's (NPSCY) $14.9B bid for $X to June, after blocking it on Jan. 3 for national security. 🔸 $ASO highlighted by Barron's for recovery potential in 2025 despite recent sales dips. 🔸 $BNED files for a $100M mixed shelf offering. 🔸 BMW saw sales decline due to China demand drop and recalls. 🔸 $BOOT Q3 EPS $2.43 vs. $2.05 est., revenue $608.2M vs. $593.45M, with 8.6% same-store sales growth. 🔸 $HSY CEO Michele Buck to retire by June 30, 2026. 🔸 $KSS to close San Bernardino EFC and 27 stores by April 2025, incurring $60M-$80M in charges. 🔸 $LULU ups Q4 EPS to $5.81-$5.85, revenue to $3.56B-$3.58B, with gross margin up 30 bps. 🔸 $JWN reports 4.9% net sales, 5.8% comp sales growth for holiday, expects 2.5%-3.5% comp sales growth for FY24.

$HSY $MDLZ - MONDELEZ NOTED TO EXPLORE TAKEOVER OF US CHOCOLATE MAKER HERSHEY

$HSY - GRIZZLY RESEARCH: ARE SHORT HERSHEY'S

#Downgrades - Sep 26, 2024 $NTRS: Goldman Sachs Downgrades to Sell from Neutral - PT $82 (from $84) $AMP: Goldman Sachs Downgrades to Neutral from Buy - PT $476 $RLJ: Wolfe Research Downgrades to Peerperform from Outperform $PK: Wolfe Research Downgrades to Peerperform from Outperform $GPN: CFRA Downgrades to Hold from Buy $JWN: KeyBanc Downgrades to Sector Weight from Overweight $SMAR: UBS Downgrades to Neutral from Buy - PT $56.50 (from $61) $SONO: Morgan Stanley Downgrades to Underweight from Overweight - PT $11 (from $25) $TNL: Barclays Downgrades to Underweight from Equalweight - PT $40 (from $46) $GEHC: UBS Downgrades to Sell from Neutral - PT $74 (from $84) $REG: Deutsche Bank Downgrades to Hold from Buy - PT $75 (from $70) $HSY: Jefferies Downgrades to Underperform from Hold - PT $163 (from $184) $FRO: SEB Equities Downgrades to Sell from Buy - PT $18.92 $RNW: Morgan Stanley Downgrades to Equalweight from Overweight - PT $7.31 (from $7.43)